<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR52">
 <label>52.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Guedj</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Dahari</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Rong</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Sansone</surname>
    <given-names>ND</given-names>
   </name>
   <name>
    <surname>Nettles</surname>
    <given-names>RE</given-names>
   </name>
   <name>
    <surname>Cotler</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Layden</surname>
    <given-names>TJ</given-names>
   </name>
   <name>
    <surname>Uprichard</surname>
    <given-names>SL</given-names>
   </name>
   <name>
    <surname>Perelson</surname>
    <given-names>AS</given-names>
   </name>
  </person-group>
  <article-title>Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life</article-title>
  <source>Proc Natl Acad Sci U S A</source>
  <year>2013</year>
  <volume>110</volume>
  <fpage>3991</fpage>
  <lpage>3996</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.1203110110</pub-id>
  <?supplied-pmid 23431163?>
  <pub-id pub-id-type="pmid">23431163</pub-id>
 </element-citation>
</ref>
